In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.

Similar Items

• In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
  od: Barchiesi, F, i dr.
  Izdano: (1994)
• In vitro studies of a new antifungal triazole, D0870, against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts.
  od: Peng, T, i dr.
  Izdano: (1993)
• In vitro antifungal susceptibility of Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus in Ethiopia
  od: Wabe, Nasir Tajure, i dr.
  Izdano: (2012)
• Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays.
  od: Venkateswarlu, K, i dr.
  Izdano: (1996)
• Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.
  od: Barchiesi, F, i dr.
  Izdano: (1994)